or Try an Advanced Search...

    Technical Analysis for SLN - Silence Therapeutics Plc

    Grade Last Price % Change Price Change
    D 18.74 -1.37% -0.26
    SLN closed down 1.37 percent on Monday, July 1, 2024, on 1.11 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical SLN trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    20 DMA Resistance Bearish -1.37%
    NR7 Range Contraction -1.37%
    Gapped Up Strength -1.37%
    Pocket Pivot Bullish Swing Setup -1.37%
    Volume Surge Other -1.37%
    Inside Day Range Contraction -1.37%
    MACD Bearish Signal Line Cross Bearish 2.35%
    Older End-of-Day Signals for SLN ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 6 hours ago
    Fell Below Previous Day's Low about 6 hours ago
    Down 1% about 6 hours ago
    Up 1% about 6 hours ago
    Possible NR7 about 6 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    SLN Chart by TradingView
    Basic chart:

    Profile

    Silence Therapeutics Plc engages in the discovery, delivery and development of ribonucleic acid (RNA) therapeutics. It develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. Its proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Acid Molecular Biology Gene Expression Genome RNA Nucleic Acids Rna Interference Molecular Genetics Gene Silencing Small Interfering Rna

    Is SLN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 24 Silence Therapeutics achieves $2M research milestone payment from Hansoh Pharma
    Jun 24 Silence Therapeutics achieves $2M research milestone payment from Hansoh collaboration
    Jun 24 Silence Therapeutics Achieves $2 Million Research Milestone Payment from Hansoh Pharma Collaboration
    Jun 21 Silence Therapeutics: PV Data For Consideration After ASCVD Treatment Results
    Jun 20 Silence releases promising phase 2 results of zerlasiran to lower lipoprotein
    Jun 20 Silence Therapeutics Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran in Patients with Elevated Lipoprotein(a)
    May 30 Silence Therapeutics to Present at Jefferies Global Healthcare Conference
    May 21 Silence Therapeutics (NASDAQ:SLN) Is In A Good Position To Deliver On Growth Plans
    May 7 Silence Therapeutics files to sell 5.71M American Depositary Shares for holders
    Apr 30 Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference
    See more SLN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 27.72
    52 Week Low 4.84
    Average Volume 141,685
    200-Day Moving Average 17.57
    50-Day Moving Average 21.16
    20-Day Moving Average 19.73
    10-Day Moving Average 19.18
    Average True Range 1.22
    RSI (14) 39.02
    ADX 19.41
    +DI 16.25
    -DI 25.46
    Chandelier Exit (Long, 3 ATRs) 18.69
    Chandelier Exit (Short, 3 ATRs) 20.89
    Upper Bollinger Bands 21.27
    Lower Bollinger Band 18.18
    Percent B (%b) 0.18
    BandWidth 15.65
    MACD Line -0.68
    MACD Signal Line -0.64
    MACD Histogram -0.0376
    Fundamentals Value
    Market Cap 724.67 Million
    Num Shares 38.7 Million
    EPS -1.49
    Price-to-Earnings (P/E) Ratio -12.58
    Price-to-Sales 31.82
    Price-to-Book 33.77
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 19.49
    Resistance 3 (R3) 19.56 19.38 19.37
    Resistance 2 (R2) 19.38 19.19 19.35 19.32
    Resistance 1 (R1) 19.06 19.07 18.97 18.99 19.28
    Pivot Point 18.88 18.88 18.84 18.85 18.88
    Support 1 (S1) 18.56 18.69 18.47 18.49 18.20
    Support 2 (S2) 18.38 18.57 18.35 18.16
    Support 3 (S3) 18.06 18.38 18.12
    Support 4 (S4) 17.99